RNA — AVIDITY BIOSCIENCES INC

Ownership history in Fiera Capital Corp  ·  5 quarters on record

This page tracks every 13F SEC filing in which Fiera Capital Corp reported a position in AVIDITY BIOSCIENCES INC (RNA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.17% (2025 Q3)
Avg. % of fund
0.08%
First filed
2024 Q3
Last filed
2025 Q3
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 1,202,384 +420,476 +53.8% 0.17% $52.4M —
2025 Q2 ADDED 781,908 +9,608 +1.2% 0.08% $22.2M —
2025 Q1 ADDED 772,300 +371,121 +92.5% 0.08% $22.8M —
2024 Q4 REDUCED 401,179 -30,031 -7.0% 0.04% $11.7M —
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    RNA price (monthly, adj. close)

Other funds also holding RNA

As of 2025 Q4 — sorted by position size

ALETHEA CAPITAL MANAGEMENT, LLC 3Y 7Y 15.62% Slotnik Capital, LLC 12.01% Twin Securities, Inc. 3Y 7Y 10.07% Sand Grove Capital Management LLP 3Y 7Y 8.11% HARVEST MANAGEMENT LLC 3Y 7Y 7.61% Slotnik Capital, LLC 6.72% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 6.39% TIG Advisors, LLC 3Y 7Y 6.02% KRYGER CAPITAL Ltd 3Y 5.82% PSquared Asset Management AG 3Y 7Y 5.68%
← Back to Fiera Capital Corp Holdings